Evidence map›Paper›PMID 36419418›Full record

ArticleFrontiers in microbiology2022

Antimicrobial activity of bovine lactoferrin against

Alessandra Pino, Tommaso Mazza, Maura-Ann H Matthews, Stefano Castellana, Cinzia Caggia, Cinzia L Randazzo, Gary A Gelbfish

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Progress in interventions for vaginal microecology.Frontiers in cellular and infection microbiology · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Proteolysis of vaginally administered bovine lactoferrin: clearance, inter-subject variability, and implications for clinical dosing.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Article
  8. Oral Intake of the Commercial Probiotic Blend SynbioJournal of clinical medicine · 2022
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Alessandra PinoDepartment of Agricultural, Food and Environment, University of Catania, Catania, Italy.
Tommaso MazzaBioinformatics Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Maura-Ann H MatthewsMetrodora Therapeutics LLC, Brooklyn, NY, United States.
Stefano CastellanaBioinformatics Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Cinzia CaggiaDepartment of Agricultural, Food and Environment, University of Catania, Catania, Italy.
Cinzia L RandazzoDepartment of Agricultural, Food and Environment, University of Catania, Catania, Italy.
Gary A GelbfishMetrodora Therapeutics LLC, Brooklyn, NY, United States.
University of Catania · ITCasa Sollievo della Sofferenza · ITIcahn School of Medicine at Mount Sinai · USIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial activitybovine lactoferrinGardnerella spp.iron-binding glycoproteinsynergistic activity

Identifiers

PMID36419418
PMCPMC9678186
OpenAlexW4295123914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.